0363-0319 : Bismuth Subsalicylate 262 mg Chewable Tablet


NDC0363-0319
Labeler: Walgreen Co.
Product Type: Human OTC Drug
Drug Name:  Soothe
Dosage Form: Oral Tablet, Chewable
Application #: part335
Rev. Date: 


Appearance:


Markings: 44;319
Shapes:  Round
Colors:  Pink
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0363-0319-01: 1 BLISTER PACK IN 1 CARTON (0363‑0319‑01) > 30 TABLET, CHEWABLE IN 1 BLISTER PACK

Active Ingredients:

  • Bismuth Subsalicylate

Dosage Strength:

  • 262 mg

Inactive Ingredients:

  • Calcium Carbonate
  • D&c Red No. 27
  • D&c Red No. 30
  • Fd&c Red No. 40
  • Magnesium Stearate
  • Mannitol
  • Povidones
  • Stearic Acid
  • Talc

Related Products:

Based on records with the same trade name.
  • 0363-0025 Soothe 525 mg/30ml Oral Liquid by Walgreens
  • 0363-0073 Soothe 525 mg/30ml Oral Liquid by Walgreens
  • 0363-0736 Soothe 525 mg/30ml Oral Liquid by Walgreens
  • 0363-7240 Soothe 525 mg/30ml Oral Liquid by Walgreens
  • 24208-495 Soothe Ophthalmic Solution/ Drops by Bausch & Lomb Incorporated
  • 24208-657 Soothe Ophthalmic Solution/ Drops by Bausch & Lomb Incorporated
  • 72587-111 Soothe Topical Patch by Bdk Group, LLC
  • 81771-7001 Soothe 25 mg/ml Topical Cream by Clay Therapy

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0363-0319 QR Code

< Prev: 0363-0318Next: 0363-0321 >

Related Discussions:

composition of bismuth subsalicylate drug
This is a drug which is used for diarrhea,a antidiarrheal drug...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.